Follow @TheHPRA
Contact us
As Gaeilge
My HPRA:
Login
Register
About Us
Medicines
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Medicines
Safety Notices
My HPRA:
Login
Register
About Us
Medicines
COVID-19 vaccines and treatments
Our Role
Medicines Information
Safety Information
Safety Notices
Quality Information
Regulatory Information
News & Events
Special Topics
Emergency Medicines
Emergency Contact Details
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Mabthera (Rituximab) - Important Safety Information from Roche as approved by the Irish Medicines Board 01.04.2007
Notice type:
3rd Party Publications
Date:
01/04/2007
Problem Or Issue:
Please find attached Safety Communication from Roche in respect of Progressive Multifocal Leukoencephalopathy (PML) in Systemic Lupus Erythematosus and Vasculitis (unapproved indications)
« Back
Date Printed: 29/03/2024